OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIV
Jake A. Ruddy, Brian J. Boyarsky, William A. Werbel, et al.
AIDS (2021) Vol. 35, Iss. 11, pp. 1872-1874
Open Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
Shi Zou, Wei Guo, Songjie Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10

Humoral immune response to two doses of COVID‐19 mRNA‐based vaccines in people living with HIV: A systematic review and meta‐analysis
Negin Farhadian, Sara Sharifi, Mahdi Taghadosi, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Closed Access | Times Cited: 5

Advances in Research on COVID-19 Vaccination for People Living with HIV
Junyan Jin, Xiuwen Wang, Raphaël Carapito, et al.
Infectious Diseases & Immunity (2022) Vol. 2, Iss. 4, pp. 213-218
Open Access | Times Cited: 8

Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus
Guiomar Casado-Fernández, Juan Cantón, Laura Nasarre, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies
Jane C. Figueiredo, Fred R. Hirsch, Lawrence H. Kushi, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 7

Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand
Yifan Li, Mélanie Merbah, Suzanne E. Wollen-Roberts, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 11, pp. 2214-2225
Open Access | Times Cited: 7

Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Songjie Wu, Yubin Zhang, Fangzhao Ming, et al.
AIDS Research and Therapy (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 9

CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study
Cecilia T. Costiniuk, Joel Singer, Marc‐André Langlois, et al.
BMJ Open (2021) Vol. 11, Iss. 12, pp. e054208-e054208
Open Access | Times Cited: 8

Booster vaccination is required to elicit and maintain COVID-19 vaccine-induced immunity in SIV-infected macaques
Pingchao Li, Qian Wang, Yizi He, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 5

Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data
N. Diaz, Rosa de Miguel Buckley, Fernando Agüero, et al.
Infectious Diseases and Therapy (2021) Vol. 11, Iss. 1, pp. 1-13
Open Access | Times Cited: 6

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study
Sabrina Manni, Caroline Ruetsch, Roxane Fabre, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2

Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV
Vitaliy Matveev, Erik Z. Mihelic, Erika Benko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

Immunogenicity of COVID-19 Vaccination in People Living with HIV: Progress and Challenges
Jin‐Wen Song, Lili Shen, Fu‐Sheng Wang
Infectious Diseases & Immunity (2023) Vol. 3, Iss. 2, pp. 90-96
Open Access | Times Cited: 2

Safety Profile of COVID-19 Vaccines in HIV Patients Undergoing ART and Their Impact on Immune Recovery and HIV Reservoirs
Bing Song, Xinhua Wang, Lin Shen, et al.
Infectious Diseases & Immunity (2024) Vol. 4, Iss. 4, pp. 178-186
Open Access

Randomised trials of COVID-19 vaccines in Africa – charting the path forward
Charles Shey Wiysonge, Duduzile Ndwandwe, Lindi Mathebula, et al.
South African Journal of Science (2022) Vol. 118, Iss. 5/6
Open Access | Times Cited: 2

Humoral Immune Response to Inactivated COVID-19 Vaccination at the 3rd Month among People Living with HIV
Songjie Wu, Shi Zou, Fangzhao Ming, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1

Safety and Immunogenicity of CoronaVac in People Living with HIV
Lucas Chaves Netto, Karim Yaqub Ibrahim, Camila de Melo Picone, et al.
SSRN Electronic Journal (2021)
Closed Access | Times Cited: 1

Quiebre en la publicación de artículos sobre la Vacuna contra el VIH mediado por la pandemia SARS-CoV-2
Ivan Aguilar Yampara, Moyra Choque Viza, Vanesa Espina Carrasco, et al.
Revista Virtual de la Sociedad Paraguaya de Medicina Interna (2023) Vol. 10, Iss. 1, pp. 29-40
Open Access

Factors associated with IgG titers against SARS-CoV-2 spike protein after second vaccination in people living with HIV controlled with anti-retroviral therapy
Kwangyeol Lee, Tetsuya Horino, Tokio Hoshina, et al.
Journal of Infection and Chemotherapy (2023) Vol. 30, Iss. 1, pp. 53-57
Closed Access

Previous Page - Page 2

Scroll to top